Last Updated: 07/09/2023

Developing genotypic methods for evaluating malaria monoclonal antibodies

Objectives

The aim of this project is to develop amplicon sequencing methods to genotype malaria parasites from patients recruited to ongoing and future phase 2 clinical trials of monoclonal antibodies.

Principal Investigators / Focal Persons

Daniel Neafsey

Date

Mar 2023 — Feb 2026

Total Project Funding

$755,000

Funding Details
Project Site

United States

SHARE
SHARE